NCT03035929View on ClinicalTrials.gov

Diagnosing Natriuretic Peptide Deficiency

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

June 8, 2017

Study Completion Date

January 1, 2018

Conditions
HealthyLean
Interventions
DRUG

Dexamethasone

A single dose of dexamethasone IV 4 mg will be administered.

Trial Locations (1)

37203

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER

NCT03035929 - Diagnosing Natriuretic Peptide Deficiency | Biotech Hunter | Biotech Hunter